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Abstract 
Vascular inflammation and atherosclerosis occur predominantly at branches and bends of arteries that 
are exposed to complex hemodynamics, whereas straight arteries exposed to unidirectional laminar flow 
are protected. Recent studies of murine arteries have revealed that complex hemodynamics are 
associated with enhanced endothelial expression of RelA, a member of the NF-κB family of 
transcription factors that regulates inflammation and apoptosis by inducing both pro-inflammatory (e.g. 
VCAM-1) and cytoprotective (e.g. A1) molecules. The distribution of NF-κB/RelA and the expression of 
NF-κB-dependent proteins in the murine aortic endothelium were evaluated by en face antibody 
staining of aortae followed by confocal microscopy and image analysis.  
 
In C57BL/6 mice, RelA expression was significantly elevated in areas of complex hemodynamics. Also, 
after lipopolysaccharide treatment, the pro-inflammatory NF-κB dependent protein VCAM-1 and the 
cytoprotective protein A1 were increased in the endothelium of this area. Furthermore, transgenic 
luciferase reporter mice revealed that NF-κB transcriptional activity was strongly induced in areas of 
complex hemodynamics. This suggests that endothelial cells exposed to complex hemodynamics may 
be primed for enhanced NF-κB activation and induction of pro-inflammatory proteins on encountering 
activatory stimuli.  
 
The protective effect of laminar flow on arteries may be a result of the activation of antioxidant genes via 
an Nrf2/EpRE-dependent transcriptional pathway. I examined this idea by assessing the expression 
levels of Nrf2 and its activity in regions of the murine aorta exposed to either complex or uniform 
hemodynamics. I observed by immunohistostaining that Nrf2 protein levels were increased in 
endothelial cells at the atherosusceptible region (exposed to complex flow) compared to the 
atheroresistant region (exposed to uniform flow). However, these data were not consistent with 
Abstract                                                                                             
 
 
 
6 
subsequent analyses of transgenic mice containing an Nrf2 (EpRE)-luciferase reporter which revealed 
that Nrf2 transcriptional activities were similar in atherosusceptible and atheroresistant regions. I 
conclude that although Nrf2 is expressed at elevated levels in atherosusceptible regions of the aorta its 
transcriptional activity is uniform throughout the aorta. These data do not support the hypothesis that 
enhanced Nrf2 activities are responsible for protecting arteries exposed to uniform hemodynamics from 
inflammation. 
 
We conclude that the hemodynamic environment in arteries may have a pivotal role in the expansion 
and progression of atherosclerotic lesion. My data suggests that NF-κB may be an important 
determinant of the susceptibility of arteries to inflammation, whereas I did not find evidence for a role for 
Nrf2. Thus the NF-κB signal transduction pathway could serve as a novel and attractive therapeutic 
target for the prevention and treatment of atherosclerosis. 
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1 Introduction 
 
 
1.1 Cardiovascular diseases/ Atherosclerosis 
Cardiovascular disease is the number one cause of death globally and is projected to remain the 
leading cause of death in the foreseeable future. An estimated 17.5 million people died from this 
condition in 2005, representing 30 % of all global deaths. The major causes are 'modifiable risk factors' 
such as tobacco use, physical inactivity and an unhealthy diet (internet reference 1). Atherosclerosis is a 
progressive condition in which patchy deposits of fatty materials, atheromas, develop in medium sized 
and large artery walls. This leads to reduced or blocked blood flow in vital organs such as brain, heart 
and kidneys and is the most important contributor to the growing burden of cardiovascular diseases.  
 
Figure 1.1 Development of atherosclerosis.  
Lipid deposition in arteries may lead to blockage of the blood stream and subsequent tissue and organ damage. 
Image adapted from internet reference 2. 
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1.2 Atherosclerosis and inflammation 
The view of the pathophysiology of atherosclerosis has evolved over the past century. From being a 
condition in which hyperlipidemia was thought to be the main factor (Ross & Harker, 1976), it is now 
acknowledged that inflammation has a prominent role in the development of this disease. Recent 
research has established a fundamental role for inflammation in mediating all stages of this disease, 
from initiation through progression and ultimately the thrombotic complications (Libby et al., 2002).  
The inflammatory response involves three major stages: first, dilation of capillaries to increase blood 
flow; second, microvascular structural changes and escape of plasma proteins from the bloodstream; 
and third, leukocyte transmigration through endothelium and accumulation at the site of injury. The main 
focus here will be on the latter stage. 
 
1.2.1 Atherosclerotic lesion development 
Early atherosclerotic lesions (fatty streaks) contain monocytes and T lymphocytes which are recruited 
from the circulation by adhesion to activated vascular endothelial cells (EC). The normal endothelium 
does not usually support binding of white blood cells; however undergoing inflammatory activation, 
arterial EC increases expression of selective adhesion molecules on their surface. In several steps, 
which all are equally important for the inflammation reaction, these adhesion molecules bind to 
leukocytes through cognate ligands. Selectins mediate a rolling interaction with the inflamed luminal 
endothelium, whilst other adhesion proteins mediate firmer attachment and eventually transmigration of 
the adherent leukocyte and finally accumulation in the intima. In particular, the immunoglobulin-like 
vascular cell adhesion molecule 1 (VCAM-1) plays a major role in leukocyte attachment by binding both 
monocytes and T-lymphocytes upon endothelial activation (Huo & Ley, 2001). The leukocyte 
transmigration requires a chemoattractant gradient. Various chemokines participates in this process, 
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monocyte chemoattractant protein 1(MCP-1) with its receptor CCR2 (Gu et al., 1998) and interferon-γ -
inducible chemokines with their receptor CXCR3 (Mach et al., 1999).  
 
 
Figure 1.2 Leukocyte transmigration upon stimulation of the inflammatory system. 
Upon endothelial activation leukocytes are accumulated in the intima through several steps. Image adapted from 
internet reference 3. 
 
In the presence of oxidized low density lipoproteins (ox-LDL), accumulated monocytes are converted to 
macrophages upon activation by macrophage colony-stimulating factor (M-CSF) among others (Clinton 
et al., 1992). By increased expression of scavenger receptors, the macrophages ingest modified 
lipoprotein particles such as cholesteryl esters which accumulate in cytoplasmic droplets. This leads 
them to differentiate into arterial foam cells which assemble in a central core in the typical 
atherosclerotic plaque. Notably, foam cells secrete reactive oxygen species (ROS) and pro-
inflammatory cytokines such as MCP-1 which can amplify the local inflammatory response in the lesion. 
They also produce matrix metalloproteinases (MMPs) which in turn can lead to destabilization and 
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consequently rupture of the plaque’s fibrous cap. This will lead to contact of the blood with another 
macrophage product called tissue factor which is a potent pro-coagulant protein. Consequently, this can 
advance the pathophysiology of cardiovascular disease by leading to thrombosis and obstruction of 
blood flow throughout the circulatory system.  
 
 
Figure 1.3 The role of the monocyte in lesion development.  
The formation of arterial foam cells is initiated by monocyte adhesion to the endothelium. Image adapted from 
(Libby, 2002). 
 
Transmigrated T-lymphocytes are also activated upon encounter with antigen such as ox-LDL and heat 
shock proteins. Crosstalk between these leukocytes and macrophages amplifies pro-inflammatory 
cytokine, MMPs and tissue factor release. Together with resident vascular wall cells, T-lymphocytes 
secrete cytokines and growth factors that can promote the migration and proliferation of smooth muscle 
cells. These may express specialized enzymes that can degrade the extracellular matrix of the growing 
plaque, leaving the fibrous cap weak and susceptible to rupture (Libby et al., 2002).  
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After formation of the fatty streak, the emerging atheroma typically evolves into a more complex lesion, 
which eventually may lead to clinical manifestations. 
 
1.2.2 The arterial endothelial cell 
The arterial endothelium survives remarkably well as the interface between blood and the vessel wall in 
an environment of constantly changing biomechanical stresses as well as acute and chronic exposure 
to inflammatory stimulants (e.g. cytokines and hypercholesterolemia respectively) (Davies, 2007). 
 
Figure 1.4 The endothelium. 
Endothelial cells line the blood vessel wall. Image obtained from internet reference 4. 
 
Endothelial cells are key regulators of the inflammatory response in the vascular system. Lining blood 
vessels, they provide in the steady state an anti-inflammatory, anti-coagulatory surface. However, in the 
case of injury or infection, EC control the adhesion and migration of blood leukocytes, as well as the 
fluid exchange from the blood stream to the damaged tissue. Thus, expression of endothelial adhesion 
molecules, cytokines and fluid exchange needs to be tightly regulated to allow for a controlled 
inflammatory response (Kadl & Leitinger, 2005). 
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1.2.3 Activation of the endothelial cell 
Several factors are known to activate EC including microbial products which may be circulating due to 
intercurrent infections. For instance, lipopolysaccharide (LPS) from the cell wall of Escherichia coli, is 
known to activate EC through Toll-like receptor 4 (TLR4) (Netea et al., 2002). In addition pro-
inflammatory cytokines such as tumor necrosis factor alpha (TNFα) and interleukin-1 (IL-1) may be 
locally produced and/or circulating due to inflammatory comorbidity (e.g. systemic lupus erythematosus 
(SLE), rheumatoid arthritis) and activate the endothelium (Haskard, 2004). Thus microbial products, 
TNFα, IL-1 and other factors activate EC, leading to increased expression of adhesion molecules and 
cytokine production which enhances recruitment and activation of leukocytes. (Kol & Libby, 1998). 
Signalling through receptors of the TNF, IL-1 or TLR families proceeds via distinct pathways that 
converge to activate the inhibitory κB kinases (IKK) which phosphorylate inhibitory κB (IκB) (Hayden & 
Ghosh, 2004). The phosphorylated form is then destabilized, thus releasing free nuclear factor kappa B 
(NF-κB) for nuclear translocation and stimulation of transcription.  
 
Figure 1.5 Activation of the NF-κB pathway through TLR and TNFR1. 
A schematic and simplified representation of the NF-κB activation. Image adapted from (Evans, 2005), modified.  
 
 
Introduction                                                                                                            
 
 
 
15 
1.3 Flow and atherosclerosis 
Atherosclerosis is a geometrically focal disease that has a predilection to branches, bifurcations and 
bends of the arterial tree. In these susceptible areas, blood flow is slow and oscillatory, resulting in a low 
hemodynamic shear stress at the endothelium. In contrast, straight vessel segments experience 
pulsatile, unidirectional laminar flow which induces a high average of shear stress on the endothelium. 
High shear stress is associated with the absence of atherosclerosis, even when plasma risk factors 
such as hypercholesterolemia are present (Zarins et al., 1983).  
 
Figure 1.6 Formation of atherosclerotic plaque at the aortic arch.  
Blood flow assumes a disturbed or turbulent pattern. Red patchy distribution indicates areas of low shear and lipid 
deposition. Arrow indicates direction of blood flow. Aortic arch from original by  G. García-Cardeña. 
 
Shear stress is a biomechanical force expressed in units of dynes/cm2 that is determined by blood 
pressure, vessel geometry and fluid viscosity (Resnick et al., 2003). Thus, the endothelium is exposed 
to diverse flow patterns; unidirectional laminar flow which promotes high shear stress and disturbed, 
oscillatory flow which expose the EC to low shear.  
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Figure 1.7 Flow patterns in the ascending and descending aorta. 
This figure shows the aorta opened to visualize the lumenal side. The upper part corresponds with the aortic arch 
which experiences disturbed flow, while the lower part is the descending aorta with laminar flow. Image adapted 
from (Motomiya & Karino, 1984). 
 
1.3.1 Mechanotransduction of shear stress 
There appears to be several possible mechanisms by which EC can sense stress and act as a shear 
transducer.  
 
Endothelial cells are specifically equipped with a dedicated sensing mechanism to detect shear stress. 
The mechanical force is amplified by shear deformation of specialized cellular mechanotransduction 
elements of the cytoskeleton. Furthermore, the cytoskeleton is coupled to the cellular membrane in a 
distributed manner by elements that include integrins, cell-cell adhesion molecules and receptors. 
Conformational changes of the specific proteins of these connecting complexes lead to an activation of 
intracellular signalling molecules, which then leads to transcriptional activity of target genes. For 
example, it has recently been demonstrated that unidirectional laminar shear can be sensed through a 
CD31/ VE-Cadherin/ VEGFR2 tri-molecular complex that converts mechanical force into biochemical 
signals (Tzima et al., 2005). 
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Primary cilium has been described for epithelial cells in the renal, bile and pancreatic duct. (Bisgrove et 
al., 2006; Satir et al., 2007). Recently, primary cilia have also been demonstrated on endothelial cells, 
especially in regions of low and disturbed hemodynamic flow. (Iomini et al., 2004; Van der Heiden et al., 
2006). It has been suggested that primary cilia elevate the shear responsiveness of endothelial cells to 
prevent atherogenic activation, but little is still know about this possible mechanism.  
 
 
Figure 1.8 Possible mechanism regarding sensing of low shear stress by endothelial cells. 
The endothelial cell is activated upon low/oscillatory shear stress. Image obtained from (Helderman et al., 2007), 
modified.  
 
1.3.2 Effects of shear stress on endothelium 
Regions exposed to low and oscillatory shear stress conditions are pro-thrombotic, pro-migratory, pro-
apoptotic and correlate well with the localization of atherosclerotic lesions. The arterial endothelium in 
these regions is activated and demonstrates increased uptake of lipoproteins, lipid deposition, increased 
surface expression of leukocyte adhesion molecules and leukocyte transmigration. All these factors 
correspond with early signs of fatty streaks and lesion formation (Malek et al., 1999; Traub & Berk, 
1998). The EC display heterogeneity in response to disturbed flow and undergo transformation of cell 
morphology. They obtain polygonal cell shapes and a random orientation that reflect the local 
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hemodynamic conditions. The EC also appear to be at a higher density in low shear regions (Hajra et al., 
2000).  
In contrast to the potentially harmful effects of low shear stress, high rates of unidirectional laminar flow 
is generally vasoprotective and associated with anti-thrombotic, anti-migration and pro-survival effects. 
(Malek et al., 1999; Traub & Berk 1998). The EC appear elongated, homogenic and tightly aligned to the 
direction of blood flow (Hajra et al., 2000). Prolonged high shear exerts several 'atheroprotective' effects 
on EC, including inhibition of the cell cycle (Lin et al., 2000), suppression of thrombosis (Grabowski et 
al., 2001) and promotion of viability (Jin et al., 2002; Taba et al., 2003; Dimmeler et al., 1996; Dimmeler 
et al., 1998; Dimmeler et al., 1999; Hermann et al., 1997). Several lines of evidence suggest that 
chronic high shear also suppresses inflammation. As an example, EC adhesion molecules are 
expressed at reduced levels at atheroprotected sites of the vasculature exposed to high shear (Hajra et 
al., 2000; Iiyama et al., 1999). Also, prolonged high shear can suppress the induction of adhesion 
molecules by pro-inflammatory cytokines in perfused aortae (Yamawaki et al., 2003) or in cultured EC 
(Dai et al., 2004; Sheikh et al., 2003; Sheikh et al., 2005; Chiu et al., 2004). 
 
1.4 NF-κB regulates endothelial activation and apoptosis  
NF-κB is a transcription factor that regulates the transcription of a large number of genes, particularly 
those involved in inflammatory, acute stress and survival responses. Through interaction with specific 
inhibitory proteins, the IκBs, NF-κB is retained in the cytoplasm in an inactive state. Proteolytic 
degradation of IκB that has been phosphorylated by IKK, liberates NF-κB to enter the nucleus and 
activates NF-κB regulated target genes. This process is eventually terminated through NF-κB-induced 
synthesis of IκBs and, consecutively, cytoplasmic resequestration of this transcription factor (Senftleben 
& Karin, 2002). 
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1.4.1 The NF-κB family 
In mammals, the NF-κB family consists of five members: NF-κB1 (p105/p52), NF-κB2 (p52/p100), RelA 
(p65), RelB and c-rel. In unstimulated cells, these family members exist as homo- or heterodimers 
bound to IκB family proteins. Heterodimers composed of p50/RelA are the most abundant form of NF-
κB in most cell types including EC. Characteristic of the NF-κB proteins are the conserved 300 amino 
acid Rel homology domain (RHD) that is located towards the N terminus. This domain is responsible for 
dimerization, interaction with IκBs, and binding to DNA (Hayden & Ghosh, 2004). 
 
 
Figure 1.9 Schematic representation of NF-κB family of proteins. 
Image obtained from (Hayden & Ghosh, 2004). 
 
1.4.2 Activation of NF-κB  
Two major signalling pathways lead to translocation of NF-κB dimers from the cytoplasm to the nucleus; 
the classical pathway, which is of most importance for this project, and the alternative pathway. In the 
classical pathway, pro-inflammatory cytokines and pathogen-associated molecular patterns (PAMPs) 
cause activation of the β-subunit of the IKK complex (complex consisting of the IKKα and IKKβ catalytic 
subunit and the IKKγ regulatory subunit, see Figure 1.10). This activation is implemented through 
receptors belonging to the TNFR and TLR/IL-1R superfamilies. The activated IKK complex catalyzes the 
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phosphorylation of IκBs on two N-terminal serine residues, which are then polyubiquitinated, targeting 
them for degradation by the proteosome. The released NF-κB dimer translocates to the nucleus, where 
it binds to sequences in promoter or enhancer regions of target genes and thereafter activate 
transcription. Signalling via this pathway results in a rapid activation of IKK and nearly complete 
degradation of IκBα within 10 min. 
 
In the alternative pathway, the homodimer IKKα is activated and phosphorylates p100 which is 
subsequently cleaved to generate a 52kD fragment that functions as the p52 NF-κB sub-unit.  
 
 
Figure 1.10 The classical NF-κB activation pathway. 
This pathway is activated by a variety of inflammatory signals, resulting in coordinate expression of multiple 
inflammatory and innate immune genes. The pro-inflammatory cytokines IL-1β and TNFα is induced in response 
to NF-κB activation, thus forming an amplifying feed forward loop. Image obtained from (Bonizzi & Karin, 2004). 
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1.4.3 Biological function of NF-κB  
NF-κB activates various target genes that is important to the pathophysiology of the vessel wall, 
including cytokines, chemokines and leukocyte adhesion molecules, as well as genes that regulate cell 
proliferation and mediate cell survival (see Figure 1.10). In addition, the IκBα gene is also activated, 
thus increasing the cytoplasmic pool of the NF-κB inhibitor. This autoregulatory system ensures that the 
induction of NF-κB is transient and that the activated cell eventually goes back to a quiescent state 
(Collins & Cybulsky, 2001).  
 
Inflammation 
It is widely established that the classical NF-κB pathway based on IKKβ-dependent IκB degradation is 
essential for innate immunity. For example, RelA and IKKβ deficiencies result in an increase in 
susceptibility to infections (Alcamo et al., 2001). The activation of NF-κB dimers, preferably the 
p50/RelA dimer, leads to the transcription of genes encoding several mediators important for the innate 
immune response to infection and injury. Notably, chemokines, cytokines, adhesion molecules (ICAM-1, 
VCAM-1 and E-selectin), enzymes that produce secondary inflammatory mediators and inhibitors of 
apoptosis (Ghosh et al., 1998).  
 
Cell viability and apoptosis 
Programmed cell death is a highly regulated process initiated by the absence of survival factors or 
presence of death-promoting factors. All cells contain components of the death machinery, ready to 
initiate self-destruction unless signalled not to do so. Cells undergoing apoptosis shrink and retract from 
neighbouring cells, this is followed by condensation of the chromatin at the nucleus membrane, whilst 
other organelles appear normal. 
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Endothelial cell apoptosis or dysfunction (loss of vasomotor tone, alteration in pro-coagulant activity and 
inflammation) is of great importance in many diseases, including atherosclerosis. In the diseased tissue, 
additional factors present (such as inflammatory cytokines) substantially alter the balance of cell 
proliferation and apoptosis to varying degrees. Specific alterations within the cell itself are also involved 
in the regulation of this balance (Stoneman & Bennett, 2004). Evidence supports a pro-active role for 
NF-κB in the inhibition of cell death induced by TNFα and other death causing agents (Van Antwerp et 
al., 1998). Interestingly, the p50/RelA heterodimer governs EC viability through the activation of 
cytoprotective genes, including Bcl-2, A1, GADD45β and MnSOD (DeSmaele et al., 2001; Duriez et al., 
2000; Wong et al., 1989).  
 
1.4.4 Target genes of NF-κB 
VCAM-1  
VCAM-1 is an immunoglobulin-like adhesion molecule that can be induced in endothelial cells exposed 
to pro-inflammatory stimuli including LPS, TNFα and ox-LDL. Similarly, in vivo studies indicate that 
VCAM-1 can be rapidly induced by atherogenic conditions in rabbits, mice and humans (Huo & Ley, 
2001). There is abundant evidence that NF-κB is required for VCAM-1 expression in activated EC. 
Firstly, the VCAM-1 promoter contains NF-κB-binding elements. Secondly, studies of cultured EC 
revealed that VCAM-1 expression can be inhibited by inhibitors of NF-κB (Collins & Cybulsky, 2001). 
Finally, VCAM-1 expression is suppressed in transgenic mice that express an IκB ‘superrepressor’ that 
blocks NF-κB activity in vascular endothelium (Henke et al., 2007).  
 
Once expressed on the surface of EC, VCAM-1 binds to the integrin a4b1 which is constitutively 
expressed on lymphocytes, monocytes and eosinophils, and induces both rolling-type adhesion and firm 
adhesion upon encounter. It is structurally similar to ICAM-1 and other endothelial adhesion molecules, 
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but has a unique distinct pattern of regulation (Huoy & Ley, 2001). Its role in atheroclerosis has been 
thoroughly demonstrated (Nakashima et al., 1998; Cybulsky et al., 2001; O’Brien et al., 1993). For 
example, by transient blocking of VCAM-1 adhesion pathways by antibodies or peptides in LDLR -/- 
mice fed a high fat diet, a reduced monocyte and lipid accumulation in lesions were obtained (Huo & 
Ley, 2001).  
 
A1  
B-cell leukemia/lymphoma 2 (Bcl-2) is a family of intracellular membrane proteins that localizes to 
mitochondria, endoplasmic reticulum and the nuclear envelope (Monaghan et al., 1992). Bcl2 proteins 
have been shown to block apoptosis without inducing cellular proliferation (Hockenbery et al., 1990). 
The pro-survival Bcl-2 homologue Bfl-1/A1 is a direct transcriptional target of NF-κB. A1 can be induced 
by TNFα in EC and it plays an essential role in protecting TNFα-treated EC from apoptosis (Duriez et 
al., 2000). Studies of A1 in immune tissues and cells support the concept that NF-κB exerts 
cytoprotective effects by inducing A1 (Zong et al., 1999). 
 
1.4.5 Nrf2 - a potential mediator of the cytoprotective effect of high shear on endothelial cells  
Oxidative signals play a significant role in the pathogenesis of chronic inflammatory diseases by 
mediating expression of inflammatory genes. However, the protective mechanisms of antioxidant 
systems remain poorly defined. The Nrf2/EpRE pathway may serve as an endogenous antioxidant 
system within the vasculature that is activated by atheroprotective laminar flow. The electrophilic 
response element (EpRE; otherwise known as the antioxidant response element (ARE)) is a 
transcriptional regulatory element that mediates expression of a set of antioxidant proteins. NF-E2-
related factor 2 (Nrf2) is a transcription factor that is responsible for both constitutive and inducible 
expression of the EpRE-regulated genes. In endothelial cells, the EpRE-mediated genes are 
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upregulated by laminar shear stress through an Nrf2-dependent mechanism. Under basal conditions, 
Nrf2 resides mainly in the cytoplasm bound to its cystein-rich, Kelch domain-containing partner, Keap1. 
On exposure to electrophile or oxidative stresses, Nrf2 is liberated from Keap1-dependent repression 
and accumulates in the nucleus to regulate the induction of a family of antioxidant genes (Kobayashi & 
Yamamoto, 2005). This suggests that Nrf2 contributes to the anti-atherosclerotic response via the EpRE. 
Nrf2 has been shown to play a part in the regulation of inflammation in both EC and macrophages 
(Hosoya et al., 2005; Chen et al., 2005). Interestingly, in EC, the over-expression of Nrf2 inhibits the 
TNFα-mediated activation of the VCAM-1 promoter (Chen et al., 2003). Consistent with these findings, 
it has also been shown that Nrf2 gene-knockout mice develop an autoimmune-like disease 
characterised by inflammation of multiple organs (Chen & Kunsch, 2004).    
 
1.4.6 NF-κB and atherosclerosis  
Using monoclonal antibodies that recognize the IκB binding region on the RelA subunit, activated NF-
κB has been identified in situ in human atherosclerotic plaques. It has also been revealed that very little 
activated NF-κB is present in healthy vessels. In models of arterial injury, NF-κB is activated in both 
endothelial and smooth muscle cells. In healthy arteries, p50 and RelA seem to have a diffuse 
expression that is restricted to the cytoplasm of EC and smooth muscle cells. However, within human 
atheromas, NF-κB sub-units accumulate in the nucleus of both cell types suggesting that the 
transcription factor is activated (Brand et al., 1996). Activated NF-κB has also been detected in intimal 
cells found in coronary arteries of pigs fed a hypercholesterolemic diet (Wilson et al., 2000). Collectively, 
these observations support a role for NF-κB in atherosclerosis. 
 
As earlier described, multiple genes whose products are thought to be involved in the atherosclerosis 
process are regulated by NF-κB. This involves both induction of genes that stimulate recruitment of 
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circulating monocytes, leukocyte transmigration and smooth muscle cell migration and proliferation. As 
a result of this activation, cytokine and chemokine release and growth factor production can be 
mediated. We can therefore conclude that NF-κB may be the key to both initial responses to the 
atherogenic signal and to subsequent amplification steps during the outspread and advancement of 
atherosclerotic lesions (Collins & Cybulsky, 2001). 
 
1.4.7 Flow, NF-κB and atherosclerosis 
The molecular mechanism underlying the anti-inflammatory and cytoprotective effects of shear stress on 
EC is uncertain. Preliminary data from the intracellular signalling group by Dr Paul Evans revealed that: 
 
1. Prolonged high shear modulates responses of cultured endothelial cells to the atherogenic cytokine 
TNFα by suppressing subsequent induction of pro-inflammatory transcripts including E-selectin, VCAM-
1 and IL-8. In contrast to the effects of shear on pro-inflammatory transcripts, it was revealed that 
prolonged high shear primes EC for enhanced expression of NF-κB-dependent cytoprotective 
molecules such as Bcl-2, A1, MnSOD and GADD45β in response to TNFα. (Partridge et al., 2007) 
 
2. In addition, preliminary studies of NF-κB-luciferase reporter mice suggested that NF-κB 
transcriptional activity was strongly induced in EC at the aortic arch by LPS whereas activity in the 
descending aorta was relatively weak. (Partridge et al., 2007) 
 
Studies by Myron Cybulsky’s group have revealed that EC exposed to relatively low shear at the lesser 
curvature of the aorta contain high levels of the RelA NF-κB sub-unit and are primed for pro-
inflammatory (e.g. VCAM-1) induction in response to LPS. (Hajra et al., 2000) 
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My study of the relationship between flow in murine arteries and pro-inflammatory activation will improve 
our understanding of the molecular mechanisms that govern the spatial distribution of atherosclerotic 
plaques. It is conceivable that findings from the proposed study may inform new therapeutic strategies 
to suppress inflammation at atherosusceptible regions by targeting NF-κB. 
 
1.5 Hypotheses 
We hypothesise that expression and activities of NF-κB transcription factors are regulated by shear 
stress in vascular endothelium in vivo. Specifically, we predict that EC exposed to low or oscillatory 
shear will be primed  for enhanced NF-κB activation and expression of pro-inflammatory proteins in 
response to pro-inflammatory stimuli e.g. LPS. In contrast, we predict that NF-κB-dependent pro-
inflammatory activation will be suppressed in EC exposed to high levels of unidirectional, laminar shear. 
We also hypothesise that the activity of Nrf2 may be enhanced in vascular endothelium exposed to high 
shear region, and that this transcription factor may play a role in atheroprotection. 
 
1.6 Specific questions to be addressed 
In this project I examined whether NF-κB activation and expression of pro-inflammatory molecules in 
murine vascular endothelium were correlated with shear stress. Thus I compared endothelial activation 
in the greater curvature of the aortic arch (exposed to high unidirectional shear) with endothelial 
activation in the lesser curvature (exposed to low oscillatory shear). I also studied the ostia (branching 
points) of the intercostal arteries which are regions exposed to abnormal hemodynamics and low 
oscillatory shear. 
 
The following specific questions were addressed: 
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1. Do expression levels of RelA NF-κB sub-units in EC vary between the greater and lesser curvatures 
of the aortic arch and branch points of the great vessels? 
 
2. Do NF-κB transcriptional activities in EC vary between the greater and lesser curvatures of the aortic 
arch and branch points of the great vessels? If so, do regions of high NF-κB activity correspond to 
regions of high RelA NF-κB protein levels? 
 
3. Do the expression patterns of VCAM-1 differ between greater and lesser curvatures and if so, do they 
correspond to the pattern of NF-κB transcriptional activity? 
 
4. Does the expression pattern of A1 differ from VCAM-1? 
 
5.  Do expression levels and activities of Nrf2 in EC vary between the greater and lesser curvatures of 
the aortic arch and branch points of the great vessels? 
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2 Materials and methods 
 
2.1 Animals  
C57BL/6 is a common inbred mouse strain and is one of the most widely used strains in the study of 
atherosclerosis and in the development of mutant mouse lines. This mouse strain was used throughout 
my immunofluorescence staining experiments. Male mice supplied from Harlan Olac Ltd were sacrificed 
at 8-12 weeks of age (20-25g). 
 
For some of my preliminary experiments a BXSB1,4 mouse strain was used. This was allowed 
optimisation of technical aspects of the work to be performed using excess animals that were available 
in the department and due to be euthanized. This recombinant inbred strain is a model for chronic 
inflammation; they are prone to the disease SLE. The mice were used at different ages and both sexes. 
 
To investigate the activity of particular transcription factors I used transgenic mice that were developed 
by Dr Harald Carlsen and Prof Rune Blomhoff at the Institute of Nutrition Research, University of Oslo. 
 
To assess NF-κB transcriptional activity in the murine aorta, transgenic mice that express a luciferase 
reporter whose transcription is dependent upon NF-κB (3x-κB-luc) were used. 3x-κB-luc male 
heterozygous mice with (C57BL/6) genetic background were sacrificed at the age of 24 weeks. 
 
A strain which reports on ARE/EpRE was used to investigate constitutive Nrf2 activity in the murine 
aorta. Female mice with (C57BL/6 x CBA) genetic bakcground were sacrificed at 40 weeks of age. 
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All experiments were performed within guidelines set by the Federation of European Laboratory Animal 
Science Association (FELASA).  
 
2.2 In vivo stimulation of aortic endothelium 
Systemic administration of LPS from gram negative bacteria wall triggers the activation of the immune 
system through the induction of cytokine release 
 
I administered varying  doses of LPS from Escherichia coli serotype 055:B5 (Sigma) which were diluted 
to a volume of 0.5 ml in phosphate-buffered saline (PBS, GIBCO) before slowly injecting it into the 
peritoneal cavity of the mouse. The duration of effect before fixation of the aortic endothelium was 
adjusted to ensure maximum expression of the protein of interest (30 minutes to 6 hours).  
 
2.3 Ex vivo stimulation of aortic endothelium 
TNFα is a major mediator of inflammation. For the experiment presented in this thesis, we used a 
carrier-free TNFα as a stimulus to induce an inflammatory effect in the murine aorta ex vivo.  
 
After CO2-euthanization of the mouse, the unfixed aorta was harvested, cleaned and opened to expose 
the endothelium. The tissue was then incubated at 37°C in cell culture medium containing 10 ng/ml 
TNFα (carrierfree, R&D systems) for 30 minutes. An aorta to serve as a control was treated the same 
way, only without the TNFα. The aortae were then fixed by immersing in formalin (2%, VWR) for 
approximately 5-10 minutes. 
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2.4 Dissection of the aorta to visualize high and low probability areas of 
atherosclerotic lesions 
Animals were CO2 euthanized before the abdomen and ribs were opened longitudinally to expose the 
thoracic cavity. The right atrium was punctured prior to gentle pressure perfusion by slowly injecting 20 
ml PBS through the left ventricle of the heart. The tissue was then pressure fixed with 20 ml formalin 
(2%, VWR) through the same route. The heart, spleen, one kidney and a part of the liver were snap-
frozen in embedding mould (CellPath) at -80º and kept for future use. The aorta and surrounding tissue 
were carefully harvested from the cadaver and stored in ice cold PBS, before thoroughly removal of 
perivascular fat. The aortic arch was cut to expose HP and LP regions en face as shown in Figure 2.1. 
 
1                                               2 
 
Figure 2.1 Dissection and mapping of HP and LP region for atherosclerotic lesion formation in mice. 
(1) The aortic arch is shown with blood stream originating from the bottom (heart not shown). Dashed lines 
indicate cuts made when dissecting the ascending aorta. (2) En face view of HP and LP regions. Small notches at 
the commissures of the aortic valve (a and b) and at the midpoint of the lesser curvature (c) served as anatomical 
landmarks. Image obtained from (Iiyama et al., 1999). 
 
 
The descending aorta was cut in two pieces, one to investigate intercostal ostia the other to serve as a 
negative control for the secondary antibody. 
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2.5 Immunohistostaining of the murine aorta en face 
The tissue was washed in PBS 1-3 times for 5 minutes between each antibody. Blocking and washing 
steps were performed in a 96-well plate, whilst all immunostaining were performed on a microscope 
slide covered in parafilm.  
 
The tissue was blocked and permeabilized in 200 µl 20% normal serum (goat serum, DAKO) and 0.5 % 
Triton-x (Sigma) in PBS overnight at room temperature (RT) (serum used depending on origin of 
species of secondary antibody). The tissue was then incubated with 100 µl primary antibody solution for 
2 hours at RT, or overnight at 4°C. The aortae were incubated in 100 µl fluorescent secondary antibody 
solution (AlexaFluor®, Invitrogen, diluted 1:1000) with 2% mouse serum (DAKO) for 2 hours at RT in the 
dark. Where applicable, the tissue was stained with 100 µl endothelial marker solution overnight at RT in 
the dark. Finally, the samples were stained with nuclear dye (diluted 1:1000) for 30 minutes (To-Pro3, 
Invitrogen) or 5 minutes (DRAQ-5, Biostatus). 
 
The aortae were put down en face onto microscope slides and mounted using non-fluorescing aqueous 
mounting medium (AquaPolymount, Polysciences). The slides were cover slipped, dried and pressed 
flat under approximately 3 kg overnight. The tissue was stored at 4°C in the dark and viewed within one 
week. 
 
2.5.1 Antibodies 
Primary antibodies were used as shown in table 2.1. 
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Table 2.1 Primary antibodies 
Primary antibody Dilution factor 
NFκB p65 [sc-372] rabbit  
(Santa Cruz Biotechnology) 
1:200 
VCAM-1 [M/K 2.7] rat 
(Generated from a hybridoma cell line available in  
the Cardiovascular Sciences Unit) 
1:200 
A1 [EP517Y] rabbit  
(AbCam) 
1:200 
Nrf2 [H-300:sc13032] rabbit 
(Santa Cruz Biotechnology) 
1:100 
AlexaFluor® 488 rat αmouse-CD31 [MEC13.3] 
(BioLegend) 
1:100 
 
AlexaFluor® secondary antibodies were used to label the proteins of interest with fluorescence.  
 
2.6 Confocal laser scanning microscopy 
Confocal laser scanning microscopy (LSM) is a method that has several advantages over conventional 
microscope techniques. It creates a sharp image which is achieved by excluding most of the light from 
the specimen that is not from the focal plan of the microscope. Unwanted light coming from other 
specimen areas is focused outside the pinhole, which passes only a small fraction of it. The pinhole 
diameter determines the thickness of the optical section. By increasing the pinhole diameter/optical 
section the out of focus regions is also increased. The smaller the pinhole, the less stray light or 
fluorescence from out-of-focus areas will hit the detector. The image will obtain increased resolution and 
contrast and represents a thin cross-section of the specimen. This method also has the ability to collect 
serial optical sections taken from the vertical axis of a thick specimen and then rearrange them back into 
three dimensional projections.  
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2.6.1 The confocal microscope used in this study 
A Zeiss LSM 510 META was used for fluorescent image acquisition. The LSM 5 software, Version 3.2, 
was used to display and analyze the images, as well as to control the microscope, scanning and laser 
modules. 
 
 
 
Figure 2.2 The confocal microscope. 
The Zeiss LSM 510 Meta (image obtained from internet reference 5). 
 
The confocal microscope works by focusing a laser light onto the specimen through an objective in a 
diffraction-limited mode. Light emitted at the focal plane and at planes below and above it is directed via 
an XY scanner onto a main dichroic beam splitter, which separates the emissions from the excitation 
light. The fluorescences are separated from each other by a series of dichroic beam splitters and 
directed to individual photomultipliers. Separately in each of the channels, the diameters of the pinholes 
and their XY positions can be optimized, and the desired emission filter placed into the beam path. 
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Figure 2.3 Basic setup of a confocal microscope. 
Light from the laser is scanned across the specimen by a beam splitter (dichromatic mirror). Optical sectioning 
occurs as the light passes through a pinhole on its way to the detector (image obtained from internet reference 5). 
 
2.6.2 Excitation of fluorophores and detection of fluorescence 
By applying dyes (fluorophores) to specimens, fluorescence can be stimulated and imaged. 
Fluorescence is emitted when the fluorophore interacts with an incident photon (excitation). Absorption 
of the photon causes an electron in the fluorophore to rise from its ground state to a higher energy level. 
Then, the electron reverts to its original level, releasing a photon (fluorescence emission) whose 
wavelength depends upon the amount of energy that is released during reversion. When the emitted 
photon has less energy than the absorbed photon, the energy difference is know as Stokes shift. 
 
It is also possible to use more than one type of fluorophore. Thus, by switching the excitation light, 
different fluorphores can be distinguished in a single specimen. Figure 2.4 shows the absorption and 
emission spectra of the fluorophores used for the experiments presented in this dissertation. 
AlexaFluor® dyes were used for their high stability and resistance to photobleaching. 
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Figure 2.4 Fluorescence spectra. 
Absorption (dotted line) and fluorescence emission spectra of AlexaFluor® -488 antibody conjugate (green), 
AlexaFluor® -568 antibody conjugate (blue), and To-Pro3 (far red) (image obtained from internet reference 6). 
 
2.6.3 Image acquisition  
A mercury lamp was used to visualize fluorescence down the microscope to situate the specimen in the 
right position for optimal imaging. Lasers featuring the appropriate wavelength to excite the dyes used to 
label the specimen were chosen (Helium-Neon laser 543 nm, 633 nm and Argon ion laser 488 nm) 
 
To remove signal from unspecific staining, a secondary only control was imaged. The level of 
background was reduced to zero using the amplifier offset. The setting for the channel which through 
the protein of interest was found was kept constant throughout all the images. 
 
The pinhole was set to 1 Airy Unit to allow detector gain setting and to provide sufficient image 
information. The detector gain was adjusted to maximum image contrast and brightness for all channels 
(except the channel of the protein of interest). By manual focusing, the microscope was set to the plane 
of endothelium with the highest protein signal. A 40/1.3 Oil Plan-Neofluar objective was used. The 
image resolution was set to 1024x1024 frame scan. Number of averages was set to 8 (mean) to 
improve signal/noise dramatically. Laser excitation intensity was set to a minimum to reduce level of 
photo bleaching.  
 
% 
λ 
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2.6.4 Data analysis 
Fluorescent staining was quantified in histograms that illustrate the mean pixel intensity per area. This 
was measured using the histogram function in the Zeiss LSM 5 software. Areas were chosen by 
manually defining an area whereas the software calculated the mean intensity inside the area. An 
example of manually defined areas for quantitation is shown in Figure 2.5. 
 
Figure 2.5 Quantitation of fluorescence intensity at endothelium and branching points of vessels.  
(A) Two rings were drawn on the image, one following the endothelial/junctional marker (green), and the other 
following the nuclei marker (blue). (B)  One ring was drawn around the intimal cushion (1), whilst an adjacent area 
served as the control (2). 
 
2.7 Luminescence detection in transgenic reporter mice 
The activity of particular transcription factors was determined in luciferase reporter mice by measuring 
light generation from samples after the administration of luciferin substrate. Some mice were treated 
with LPS prior to sacrifice whereas other remained untreated. Aortae were carefully harvested from 
freshly sacrificed transgenic luciferase mice. The tissue was thoroughly cleaned of external fat and 
aortae were opened longitudinally along the lesser curvature to visualize the endothelium. All 
manipulations were performed in culture medium to maintain cell viability. The aortae were then 
immersed en face in cell culture medium containing 1.5 mg/ml D-luciferin substrate (Biosynth, Staad, 
Switzerland).  
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2.7.1 Low resolution luminescence imaging 
Prior to high resolution luminescence imaging, the samples were screened for luciferase activity using 
the IVIS 100 system from Xenogen. This was useful in determining the exposure length for the high 
resolution imaging (which could be increased in the case of low luminescence). Software used for image 
acquisition was Living Image 2.20 from Xenogen.  
 
2.7.2 High resolution luminescence imaging 
The macro imaging system used was Andor iXon+ EMCCD camera (DU897E-CSO-#BV) 512x512 
pixels, back-illuminated CCD with on-chip electron multiplication. Software used for image acquisition 
was Andor Solis. Luminescence images were acquired using a Schneider-Kreuznach Xenon 25 mm 
f/0.95 lens at full aperture opening. A 15 mm extension tube was fitted between the lens and the CCD 
camera, in order to increase optical magnification and light collection efficiency. 
 
The charge coupled device (CCD) chip was cooled to -100°C with a thermo-electric element, which in 
turn was water-cooled. Deep cooling of the CCD ensures that false signal due to thermal events (dark 
current) is negligible. In addition, the effective read-noise was reduced to below one photon per pixel by 
using on chip electron multiplication with a high gain.  
 
Camera settings for luminescence imaging were:   
Exposure time 30 minutes (typically an accumulated image of 6 x 5 minutes)  
EMCCD gain 200  
16 bit 1 MHz a/D read-out  
CCD temperature -100ºC 
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2.7.3 High resolution reflected light imaging 
To obtain high resolution reflected light images, a stereo microscope was used (Leica MZ Apo with a 
Planapo 1.0x objective 100 W fibre-coupled tungsten lamp used for epi-, trans- and dark-field 
illumination).  
 
Despite its higher resolution and optical quality, the stereomicroscope was not used for luminescence 
imaging, due to poorer light gathering power - estimated to be 10% of that of the Schneider lens with 
extension tube. 
 
2.7.4 Data analysis 
Luminescence was analyzed and measured using ImageJ software version 1.37v. 
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3 Results 
 
3.1 Correlation between endothelial cell morphology and atherosusceptible and 
atheroresistant regions in the murine aorta 
As earlier described, regional differences in hemodynamic flow in the aorta are associated with either 
protection or susceptibility of formation of atherosclerotic lesions. Areas exposed to disturbed flow have 
a higher probability of lesion formation (HP), whereas areas exposed to laminar flow are protected and 
have a low probability of lesion formation (LP). The location of lesion development is highly reproducible, 
particularly in the ascending aorta and arch. The HP area is located in the lesser curvature and the LP 
area in the greater curvature of the aortic arch.  
 
Previous studies have shown that EC morphology reflects the local hemodynamic environment (Hajra et 
al., 2000). The first aim of my project was to identify HP and LP regions in the mouse aorta and validate 
them by defining EC morphology.  
 
Immunostaining for CD31 (a marker for EC) followed by confocal microscopy showed that EC in the LP 
region were elongated and organized in a parallel pattern to the direction of blood flow (Figure 3.1, right 
panel). On the other hand, EC in the HP region possessed polygonal, irregular shapes and were 
randomly oriented relative to flow direction (Figure 3.1, left panel). The morphology of endothelial nuclei  
also correlated with the flow pattern in these areas and appeared to be oval and organized in the LP 
area, where in HP areas they were less organized (Fig 3.1, compare right and left panel).  
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Figure 3.1 The morphology of endothelial cells in HP and LP regions of the murine aorta. 
Aorta from an untreated BXSB 1,4 mouse was harvested, fixed and stained en face using 488 labelled anti-CD31 
antibody (green). Nuclei were counterstained using 633-labelled To-Pro3 (blue). Fluorescence at the lumenal 
surface of HP and LP sites of the aortic arch was detected using confocal LSM. Note that EC in the HP region 
have variable shapes and random orientation, whereas in the LP region they are elongated and aligned in the 
direction of blood flow (top to bottom). 
 
3.2 Induction of inflammatory response in vascular endothelium 
I examined whether there were differences in the susceptibility of EC in HP and LP regions to the 
proinflammatory effects of stimuli such as TNFα and LPS. Although the atherogenic contribution of 
acute activation is uncertain, inflammatory mediators produced by both acute and chronic infections are 
thought to modulate the development of atherosclerotic lesions. In the first instance, I studied NF-κB 
which is known to be activated through exposure of cells to cytokines, chemokines, viruses and 
bacterial lipopolysaccharides (LPS) among other things and to drive the inflammatory response. To 
assess the degree of NF-κB activation, we used immunofluorescence staining and confocal microscopy 
to monitor the nuclear translocation of the NF-κB subunit RelA.  
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3.2.1 Responses of murine aortae to TNF-α treatment ex vivo 
TNFα is a pro-inflammatory cytokine which through TNFR1 activation may elicit NF-κB-dependent 
pathways. To assess its function in murine aortic EC, aortae were harvested and treated with TNFα 
before fixation and immunostaining. 
 
In untreated vessels, I observed that RelA was predominantly cytoplasmic in EC in both HP and LP 
regions (Figure 3.2, panels 1-6). Treatment with TNFα led to nuclear localisation of RelA in 
approximately 50% of the EC in both HP and LP regions (Figure 3.2, panels 7-12). 
 
By comparison with the effects of TNFα on cultured EC which induces RelA nuclear localization in all 
cells (Partridge et al., 2007), we were surprised at the inconsistent response of murine aortic EC to 
TNFα applied ex vivo. The unequal response of EC in this experiment may be due to mechanical forces 
imposed on the EC during the process of dissection and cleaning of the aorta, which may have altered 
their physiology 
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Figure 3.2 Induction of inflammatory response in vascular endothelium ex vivo. 
Aortae from untreated BXSB 1,4 mice were harvested and incubated at 37°C in medium for 30 min (Panels 1-6) 
or 10 ng/ml TNFα in medium for 30 min (Panels 7-12) (n=1 in each group). Aortae were then fixed and stained en 
face using anti-RelA primary antibodies and AlexaFluor 488-conjugated secondary antibodies (green). Nuclei 
were counterstained using 633-labelled To-Pro3 (blue). Fluorescence at the lumenal surface of HP and LP sites 
of the aortic arch was detected using confocal LSM. Note that EC in both HP and LP areas show an incomplete 
translocation of RelA from the cytosol to the nucleus in response to TNFα.  
 
3.2.2 LPS stimulation in vivo 
As stimulation did not induce a complete translocation of RelA from the cytosol to the nucleus in EC ex 
vivo, we decided to administer a pro-inflammatory stimulus in vivo. We chose to use LPS instead of 
TNFα because LPS has generated more reliable and consistent pro-inflammatory activation in vivo in 
our experience (Partridge et al., 2007). Other investigators have shown that administrating 100 µg (5 
mg/kg) LPS to the intraperitoneal cavity gives an acute systemic activation of vascular endothelium 
(Hajra et al., 2000). In the first instance I examined the effects of varying doses of LPS (50 µg or 100 µg) 
on NF-κB nuclear translocation in aortic EC. 
 
Immunostaining showed that 50 µg and 100 µg LPS provoked a translocation of RelA from the cytosol 
to the nucleus in both HP and LP regions of the murine aorta. Figure 3.3 show that RelA was detected 
exclusively in the nucleus of EC of treated animals and I concluded that a dose of 50 µg LPS is 
sufficient for an acute systemic activation. 
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Fig 3.3 Induction of inflammatory response in vascular endothelium in vivo. 
BXSB 1,4 mice were treated with 0, 50 or 100 µg LPS i.p. for 30 min (n=2). Aortae were harvested, fixed and 
stained en face using anti-RelA primary antibodies and AlexaFluor 488-labelled secondary antibodies (green). 
Nuclei were counterstained using 633-labelled To-Pro3 (blue). Fluorescence at the lumenal surface of HP and LP 
sites of the aortic arch was detected using confocal LSM. Representative images of HP and LP regions obtained 
from the same mouse are shown.  Note that doses of both 50 and 100 µg LPS (panels 7-18) induce a 
translocation of RelA from the cytosol to the nucleus in both HP and LP sites compared to the control (panels 1-6). 
 
3.3 Spatial distribution of NF-κB expression and activities in the murine aorta 
Previous data from the Intracellular Signalling group have shown that shear stress and TNFα alters the 
intracellular localization of RelA in human umbilical vein endothelial cells (HUVEC). It has also been 
shown that EC in the aortic arch of transgenic NF-κB luciferase reporter mice were primed for enhanced 
NF-κB activation in response to TNFα (Partridge et al., 2007). To validate and extend these data, I 
looked at the distribution of the RelA subunit as well as NF-κB luciferase activity in EC in vivo.  
  
3.3.1 RelA levels in regions protected and susceptible to atherosclerotic lesion formation 
Immunostaining and confocal microscopy revealed that RelA protein levels are significantly elevated in 
the HP region compared to the LP region (Figure 3.4 A, compare panels 1 and 4; Figure 3.4 B, upper 
panels). The proportion of RelA in the nucleus versus the cytosol is also significantly increased in the 
HP region (in the absence of LPS) (Figure 3.4 A, panel 1-3; Figure 3.4 B, panel 3). These data suggest 
that the HP area may be primed for pro-inflammatory activation. Upon acute systemic stimulation of the 
immune system via LPS injection, RelA translocated to the nucleus in both HP and LP regions (Figure 
3.4 A, 7-12; Figure 3.4C, panels 2 and 4). The extent of NF-κB translocation in response to LPS was 
similar in both regions as assessed by quantitation of RelA in nuclear or cytoplasmic regions (Figure 3.4 
B, panel 4) or by examining co-localization of RelA with a nuclear marker (Figure 3.4 C). 
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Fig 3.4 The spatial distribution of RelA in the murine aortic arch 
(A) C57BL/6 mice were injected with 50 µg LPS i.p. for 30 minutes (panels 7-12) or remained untreated as 
controls (panels 1-6) (n=4 in each group). Aortae were fixed and then stained en face using anti-RelA primary 
antibodies and AlexaFluor 488-conjugated secondary antibodies (green). Nuclei were counterstained using 633-
labelled To-Pro3 (blue). Fluorescence at the lumenal surface of HP and LP sites of the aortic arch was detected 
using confocal LSM. Representative images of HP and LP regions obtained from the same mouse are shown. (B) 
Fluorescence was quantified in 100-150 cells randomly selected from 5-10 images of each area. RelA levels were 
quantified in whole cells (TOTAL) or in nuclei (NUCLEAR) of EC from untreated animals (upper panels). The ratio 
of nuclear: cytoplasmic RelA, which is a measure of NF-κB activation, was calculated for EC of untreated or 
treated animals (lower panels). Data are shown as means ±SEM (arbitrary units, A.U.). Differences between 
samples were analyzed using a paired t-test (***p<0.0001). (C) NF-κB nuclear localisation was also examined by 
determining the extent of co-localization of RelA and To-Pro3 by measuring fluorescence intensity through cross 
sections of 3-5 cells for each image. The position of the cross sections was chosen manually and is represented 
as a red line in the images (upper panels). Fluorescence intensities through cross sections were plotted (lower 
panels). Note the co-localisation of RelA and nuclei in EC at HP or LP sites of LPS-treated animals, indicating 
that RelA translocates to the nucleus in response to LPS in both regions. 
 
Confirmation of results by co-staining of EC using anti-RelA and anti-CD31 antibodies 
In the previous section I identified EC using confocal microscopy by focusing on the lumenal side of the 
aorta and by reference to anatomical details, including nuclear morphology. However, to confirm that 
RelA expression levels are elevated in endothelial cells at HP sites we performed co-staining using anti-
RelA and anti-CD31 (an endothelial marker) antibodies. These findings (Figure 3.5) show conclusively 
that RelA is found to lesser extent in LP regions than HP regions in untreated endothelium, thereby 
confirming our previous analysis.   
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Fig 3.5 Assesment of RelA level in murine aortic endothelial cells. 
C57BL/6 mice were injected with 50 µg LPS i.p. for 30 minutes (panels 9-16) or left untreated as controls (panels 
1-8) (n=2 in each group). Aortae were fixed and then stained en face using anti-RelA primary antibodies and 
AlexaFluor 568-conjugated secondary antibodies (red). The endothelium was then stained using a 488-labelled 
anti-CD31 antibody (green). Nuclei were counterstained in all samples using 633-labelled DRAQ5 (blue). 
Fluorescence at the lumenal surface of HP and LP sites of the aortic arch was detected using confocal LSM. 
Representative images of HP and LP regions obtained from the same mouse are shown.  
 
3.3.2 NF-κB transcriptional activity in HP and LP regions of murine aorta 
Transgenic NF-κB luciferase reporter mice were used to assess the spatial distribution of NF-κB 
transcriptional activity in murine aortic endothelium in vivo. In particular, I focused on the HP and LP 
regions that were defined by the group of Myron Cybulsky (Iiyama et al., 1999).  
 
NF-κB-driven luciferase activity was very low in aortae from untreated animals (Figure 3.6 A, panel 1). 
LPS treatment elevated NF-κB activity in EC in the aortic arch and upper parts of the thoracic 
descending aorta (Figure 3.6 A, panels 2-5). Quantitative analysis also revealed that NF-κB was 
elevated to a greater extent in HP compared to LP regions (Figure 3.6 B). This indicates that EC in the 
HP region of the aortic arch are primed for enhanced NF-κB transcriptional activation in response to 
LPS. 
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B             
 
Fig 3.6 Constitutive and LPS-induced NF-κB transcriptional activity in the murine aortic endothelium. 
(A) Transgenic NF-κB-luciferase mice were either left untreated (panel 1), or treated with 50 µg LPS i.p. for 4h 
(panels 2-5). Aortae were harvested, opened longitudinally and immersed in 1.5 mg/ml luciferin substrate in 
medium. Luciferase activity at endothelial surfaces was assessed by measuring luminescence at the lumenal side 
of the vessel (pseudocoloured). Reflected light images were obtained and are also shown. The arch and 
descending aorta are indicated with a and b respectively. (B) Luminescence intensity was measured at LP and 
HP sites of treated aortae (n=4). A representative image is shown with LP and HP sites indicated. Rates of 
photon detection are shown as means ±SD after subtracting background signals. Differences between samples 
were analyzed using a paired t-test (*p=0.0275). Note that EC in the HP region in the aortic arch possessed 
enhanced NF-κB activation in response to LPS. 
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3.3.3 NF-κB expression and activity at intercostal ostia 
The intercostial ostias are branching sites of the aortic vessels, which can be seen as paired orifices 
along the aorta. These sites are exposed to abnormal hemodynamics and are susceptible to 
inflammation and atherosclerosis. In mice, an intimal “cushion” is found upstream of the orifice. The 
function of this cushion is uncertain, but it may influence mixing of blood to ensure sufficient blood 
supply to aortic branches. The intimal cushion consists of smooth muscle cells covered by an 
endothelial layer. 
 
Spatial variation in NF-κB expression levels at intercostal ostia 
We wanted to examine the expression of NF-κB/RelA in EC surrounding the ostia and to compare it 
with adjacent regions that are resistant to atherosclerosis and exposed to normal flow patterns 
 
To investigate to which extent RelA is distributed in/around the ostia, we performed 
immunofluorescence staining in the descending aortae followed by confocal microscopy. Quantitative 
studies of 8 ostia revealed that RelA levels are elevated in EC that surrounded the intimal cushion 
compared to adjacent EC experiencing unidirectional laminar flow (Figure 3.7).  
A 
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Figure 3.7 RelA distribution at intercostal ostias. 
Aortae from untreated C57BL/6 (n=4) were fixed and then stained en face using anti-RelA primary antibodies and 
AlexaFluor 488-conjugated secondary antibodies (green). Fluorescence at ostia (n=8) was measured by making 
optical sections of the tissue using confocal LSM and rearranging images back into 3D projections. (A) (1) A 
single optical slice through an ostium is shown from the lumenal side of the descending aorta, (2) Pseudo3D 
images showing RelA staining intensity were obtained using the LSM software. The arrows show the direction of 
blood flow. (B) Fluorescence was quantified in 8 ostias for the intimal cushion and from adjacent areas exposed 
to laminar flow (Control). Data are shown as means ±SD. Differences between samples were analyzed using a 
paired t-test (***p=0.0003). 
 
NF-κB luciferase activity in aorta at sites of disturbed flow  
We have earlier seen that NF-κB transcriptional activity in transgenic NF-κB-reporter mice is enhanced 
at HP sites of the aortic arch in response to LPS. To assess if this is the same case with the intercostal 
ostia (which are also highly susceptible to atherosclerosis) we set up parallel experiments focusing on 
the descending aorta and ostia of intercostals arteries.  
 
We could see that NF-κB activation in response to LPS was elevated in some of the intercostal ostias 
compared to adjacent regions (Figure 3.8 A and B). I conclude therefore that EC exposed to abnormal 
hemodynamics at the intercostal ostia contain elevated levels of NF-κB proteins and are primed for 
enhanced NF-κB activation in response to LPS. 
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Figure 3.8 LPS-induced NF-κB transcriptional activity at areas exposed to disturbed and laminar flow. 
(A) Transgenic NF-κB-luciferase mice (n=2) were treated with 50 µg LPS i.p. for 4h. Aortae were harvested, 
opened longitudinally and immersed in 1.5 mg/ml luciferin substrate in medium. Representative images are 
shown. Luciferase activity at endothelial surfaces was assessed by measuring luminescence at the lumenal side 
of the vessel (panel 1, pseudocoloured). Reflected light images of the aortae were obtained (panel 2), and 
overlaid with luminescence images to locate luminescence at intercostal ostias (panel 3). (B) Rates of photon 
detection at ostias and adjacent areas (Control) are shown as means ±SD. Differences between samples were 
analyzed using a paired t-test (*** p<0.0001). Note that EC at ostias possessed enhanced NF-κB activities 
compared to adjacent sites. 
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3.4 Expression of NF-κB target genes in atherosusceptible and atheroresistant 
regions of the aorta  
The preliminary data from our lab revealed that pre-shearing had highly selective effects on 
transcriptional targets of TNFα, by suppressing pro-inflammatory transcripts but enhancing 
cytoprotective transcripts in vitro (Partridge et al., 2007). We wanted to investigate whether these 
findings could be valid in vivo, and to which extent the distribution of these transcripts in the murine 
aorta were correlated with NF-κB activity.  
 
3.4.1 Spatial distribution of VCAM-1 
 
As we can see in the unstimulated animals VCAM-1 was expressed at very low levels (Figure 3.9 A, 
panels 1-8; Figure 3.9 B). Upon LPS stimulation in vivo, VCAM-1 was significantly elevated in both HP 
and LP regions, but to a greater extent in HP regions (Figure 3.9 A, panels 9-16; Figure 3.9 B). These 
results indicate that VCAM-1 expression is tightly correlated with enhanced NF-κB activity in HP regions. 
We can therefore conclude that EC in the HP region are primed for pro-inflammatory activation.  
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Fig 3.9 VCAM-1 expression in the aortic endothelium. 
(A) C57BL/6 mice were injected with 50 µg LPS i.p. for 6h (panels 9-16) or remained untreated as controls 
(panels 1-8) (n=4 in each group). Aortae were fixed and then stained en face using anti-VCAM-1 primary 
antibodies and AlexaFluor 568-conjugated secondary antibodies (red). The endothelium was stained using a 488-
labelled anti-CD31 antibody (green). Nuclei were counterstained in all samples using 633-labelled DRAQ5 (blue). 
Fluorescence at the lumenal surface of HP and LP sites of the aortic arch was detected using confocal LSM. 
Representative images of HP and LP regions obtained from the same mouse are shown. (B) Fluorescence was 
quantified in 100-150 cells randomly selected from 5-10 images of each area. Data are shown as means ±SEM. 
Differences between samples were analyzed using a paired t-test (*p=0.0162, ***p<0.0001). Endothelial cells 
expressed higher levels of VCAM-1 in response to LPS in HP than in LP areas of the aortic arch.  
 
3.4.2 Distribution of A1 in the murine aorta  
 
A1 is an anti-apoptotic Bcl-2 homologue that is known to be activated through the NF-κB route and 
induces cell viability. To assess the expression of A1 in the murine aorta in response to LPS we 
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performed a preliminary study in BXSB 1,4 mice which are prone to a lupus-like autoimmune syndrome 
(an excess of these animals were available in the unit).  
 
This experiment showed that A1 has a low constitutive distribution (Figure 3.10 A, panels 1-8; Figure 
3.10 B) and was induced modestly in response to LPS (Figure 3.10 A, panels 9-16; Figure 3.10 B). 
There was no significant difference in A1 expression in areas exposed to laminar or disturbed flow. 
These findings now need to be validated in a wild type mice strain (C57BL/6). 
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Figure 3.10 Spatial distribution of A1 in the murine aorta.  
(A) BXSB 1,4 mice were injected with 50 µg LPS i.p. for 5h (panels 9-16) or left untreated as controls (panels 1-8) 
(n=2 in each group). Aortae were fixed and then stained en face using anti-A1 primary antibodies and AlexaFluor 
568-conjugated secondary antibodies (red). The endothelium was stained using a 488-labelled anti-CD31 
antibody (green). Nuclei were counterstained using 633-labelled DRAQ5 (blue) in all samples. Fluorescence at 
the lumenal surface of HP and LP sites of the aortic arch was detected using confocal LSM. Representative 
images of HP and LP regions obtained from the same mouse are shown. (B) Fluorescence was quantified in 100-
150 cells randomly selected from 5-10 images of each area. Data are shown as means ±SEM. Differences 
between samples were analyzed using a paired t-test (ns). A1 experiences a modest up-regulation upon systemic 
stimulation of the immune system, and is distributed similarly in HP and LP areas of the aortic arch.  
 
 
3.5 Spatial distribution of Nrf2 in areas exposed to disturbed and laminar flow 
 
Recent studies have shown that Nrf2 is a critical transcription factor that regulates several genes 
contributing to important cellular defence mechanisms against the toxicity of electrophiles and ROS 
(Kobayashi & Yamamoto, 2005). It has also been shown that Nrf2 is regulated by laminar and oscillatory 
flow in human EC (Hosoya et al., 2005). We wanted to investigate whether Nrf2 is activated in 
atheroprotected regions in the mouse aorta.  
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3.5.1 Nrf2 expression and activity in atherosusceptible regions of the murine aorta 
By confocal immunofluorescence microscopy we examined the constitutive Nrf2 protein levels in the 
murine aorta. Figure 3.11 show that Nrf2 expression is predominant in the HP region of the aortic arch 
(Figure 3.11 A, compare panels 1 and 5; Figure 3.11 B).  
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Figure 3.11 Spatial distribution of Nrf2 in the murine aorta. 
(A) Aortae from C57BL/6 mice were fixed and then stained en face using anti-Nrf2 primary antibodies and 
AlexaFluor 568-conjugated secondary antibodies (red). The endothelium was stained using a 488-labelled anti-
CD31 antibody (green). Nuclei were counterstained using 633-labelled DRAQ5 (blue). Fluorescence at the 
lumenal surface of HP and LP sites of the aortic arch was detected using confocal LSM. Representative images 
of HP and LP regions obtained from the same mouse are shown. (B) Fluorescence was quantified in 100-150 
cells randomly selected from 5-10 images of each area. Data are shown as means ±SEM. Differences between 
samples were analyzed using a paired t-test (*p=0.0162, ***p<0.0001).  
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We were also interested in assessing whether Nrf2 was activated in regions exposed to atheroprotectice 
hemodynamic flow, as earlier shown by other groups (Dai et al., 2007). To do this we measured the 
nuclear/cytoplasmic ratio of Nrf2 in both HP and LP regions (note that Nrf2 enters the nucleus upon 
activation). As we can se in Figure 3.12, there were no significant differences in Nrf2 translocation 
between the two regions (Figure 3.12 B). 
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Figure 3.12 Nrf2 activity level at HP and LP sites of the aortic arch. 
Aortae from untreated C57BL/6 mice (n=4) were harvested, fixed and then stained en face using anti-Nrf2 
primary antibodies and AlexaFluor 568-conjugated secondary antibodies (red). The endothelium was stained 
using a 488-labelled anti-CD31 antibody (green). Nuclei were counterstained in all samples using 633-labelled 
DRAQ5 (blue). Fluorescence at the lumenal surface of HP and LP sites of the aortic arch was detected using 
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confocal LSM. The detector gain for the 568 channel was turned down at both sites for optimal visualization of 
cytoplasmic and nuclear compartments. (B) Fluorescence was quantified in 100-150 cells randomly selected from 
5-10 images of each area. Data are shown as means ±SEM. Differences between samples were analyzed using 
a paired t-test (ns).   
 
 
3.5.2 Nrf2 luciferase transcriptional activity in the murine aortic endothelium 
To further investigate the expression of Nrf2 in the murine aorta, we looked at transgenic luciferase 
reporter mice. There was no distinct pattern of Nrf2 activities in the aorta and we observed similar Nrf2-
luciferase activities in atherosusceptible (lesser curvature of aortic arch, ostia) and atheroresistant 
(greater curvature, descending thoracic aorta) regions (Figure 3.13 A, panels 1-4; Figure 3.13 C). It is 
plausible however that the resolution of this system is insufficient to identify potential differences 
between neighbouring cells. Thus immunostaining of aortae from Nrf2-luciferase animals using anti-
luciferase antibodies should now be carried out to assess Nrf2 activity at a single cell resolution. 
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Fig 3.13 Constitutive Nrf2 transcriptional activity in the murine aortic endothelium. 
(A) Aortae from transgenic Nrf2-luciferase mice (n=4) were harvested, opened longitudinally and immersed in 1.5 
mg/ml luciferin substrate in medium. Luciferase activity at endothelial surfaces was assessed by measuring 
luminescence at the lumenal side of the vessel (pseudocoloured). Reflected light images were obtained and are 
also shown. (B) Luciferase activity was abolished in the endothelium by gentle scraping of the luminal side of the 
lower descending aorta. Images show aorta before (1) and after (2) scraping. (C) Luminescence intensity was 
measured at LP and HP sites. A representative image is shown. Rates of photon detection are shown as means 
±SD after subtracting background signals. Differences between samples were analyzed using a paired t-test (ns). 
Note that endothelial cells in the HP region in the aortic arch show no increased Nrf2 transcriptional activity 
compared to LP region. 
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4 Discussion 
 
4.1 Endothelial cell morphology in atherosusceptible and atheroresistant regions 
in the murine aorta  
Endothelial cells, which line the vessel wall and regulate vascular homeostasis, are sensitive to shear 
stress which is a mechanical force generated at endothelial surfaces by flowing blood. One marker of 
endothelial dysfunction in vivo is the disorganization of cell shapes.  
 
Our findings revealed that endothelial cells in a region of the aorta that is resistant to atherosclerosis 
(called LP for ‘low probability’) were elongated and organized in a parallel pattern to the direction of 
blood flow. Nuclei in this area were also well organized and appeared to be oval. Cultured EC are 
known to align themselves in response to shear stress, thus it is likely that EC in the LP region are 
orientated as a result of physiological responses to the hemodynamic flow pattern. In the HP region 
(high probability of atherosclerosis) where EC are exposed to low oscillatory shear, they possessed 
polygonal, irregular shapes and were randomly oriented relative to the direction of blood flow. The nuclei 
were also less organized than in the LP area.  
 
Other investigators have also revealed that the endothelial cell morphology reflects the surrounding 
hemodynamic environment in vivo (Hajra et al., 2001, Passerini et al., 2004). I found that this 
morphology pattern was highly reproducible for the HP and LP region in the murine aorta. To a certain 
extent this was also used as a tool for confirming the correct identification of these regions in the aortic 
arch.  
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The mechanosensitive molecular mechanisms that determine shear stress-mediated endothelial shape 
change remain controversial. Still, a growing body of evidence supports an integrated signaling network 
in which cytoskeletal polymers transmit apical shear forces to membrane attachment sites at which 
conformational changes in associated proteins initiate signalling. During cell locomotion and shape 
change events, the actin cytoskeleton is remodelled extensively, primarily by adding and subtracting 
subunits at free filament ends. Cytoskeletal remodelling also occurs in response to fluid shear stress in 
endothelial cells. The effect of high shear streamlines the endothelial cell and reduces the peak shear 
stresses imposed on individual cells (Osborn et al., 2006). Thus the characteristic elongated 
morphology of endothelial cells in atheroresistant sites exposed to high rates of unidirectional flow may 
result from cytoskeletal changes in response to shear stress. 
 
4.2 Spatial distribution of NF-κB in the murine aorta  
Current data implicate NF-κB as a key regulator of shear stress-induced inflammatory gene expression. 
The expression of NF-κB sub-units and pro-inflammatory proteins (e.g. VCAM-1, E-selectin) is elevated 
in atherosclerosis-prone regions before or in the absence of fatty streak formation, indicating that they 
may be very early events in the atherosclerotic progression (Nakashima et al., 1998; Iiyama et al., 1999; 
Wilson et al., 2000). One of my aims was to establish whether there is a correlation between flow and 
NF-κB transcriptional activity in vivo, a subject that has not previously been investigated. 
 
4.2.1 The NF-κB subunit RelA display increased expression and activity in athero-prone sites 
of the murine aorta 
My findings revealed that RelA protein levels were significantly greater in the HP compared to the LP 
region in unstimulated murine aorta, thus supporting a previous study (Hajra et al., 2000). This 
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observation may be linked to the unique hemodynamic properties of these areas. The HP area, in which 
EC express high levels of RelA protein, is exposed to low hemodynamic shear. In contrast, EC in the LP 
region are exposed to protective, high shear and express low levels of RelA. Also, constitutive nuclear 
localization of RelA was significantly elevated in areas of low shear, hence suggesting but not proving 
that this region may be associated with increased NF-κB transcriptional activity. Collectively, these 
findings suggest that the HP area may be primed for NF-κB dependent pro-inflammatory activation. In 
contrast, the relatively low levels of RelA in the LP region would imply that NF-κB activity may be 
reduced in this area compared to the HP region. 
 
By challenging endothelial cells with LPS for 30 minutes in vivo, I found a complete translocation of 
RelA to the nucleus in both HP and LP regions. This particular finding does not support Myron 
Cybulsky’s group, who suggested that nuclear translocation of RelA exclusively in the HP region in 
response to LPS (Hajra et al., 2000). Interestingly, this group conceded in their paper that the absence 
of RelA nuclear localization in LP regions in LPS-treated mice could have been due to an experimental 
artifact as low-level signal quantitation was diminished in their system. I conclude therefore that my 
observations may differ from those of Cybulsky due to the superior sensitivity of the 
immunostaining/confocal microscopy method that I used to measure RelA levels.  I also concluded that 
NF-κB activity in the LP region therefore needs to be assessed in a more robust manner, specifically by 
using a high-sensitivity reporter system. 
 
4.2.2 NF-κB transcriptional activity is elevated in HP vs. LP regions of the murine aorta in 
response to LPS 
To assess directly the spatial distribution of NF-κB transcriptional activity in aortic endothelium, I used a 
transgenic strain of mice containing an NF-κB-luciferase reporter. Reporter gene systems are beneficial 
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in this setting because they are highly sensitive, amendable to quantitation and provide a direct 
measurement of transcriptional activity. Previously, transgenic reporter mice have successfully been 
used to investigate the eNOS promoter activity in vascular endothelium in vivo (Cheng et al., 2005).  
 
By measuring endothelial luminescence in the aortic arch and the descending aorta, I found that NF-κB 
was activated by 4 hours of LPS in not only the HP, but also in the LP region of the aorta. I found a 
significant difference in these two regions, where NF- κB transcriptional activity was strongly induced in 
the HP region in contrast to the LP region. This indicates that endothelial cells in the HP region of the 
aortic arch are primed for enhanced NF-κB activation.  
 
4.2.3 NF-κB activity is elevated in regions of the murine aorta exposed to abnormal 
hemodynamic flow  
As earlier described, the intercostal ostia are areas of the descending aorta with disturbed, abnormal 
blood flow. The intimal cushion, which in part is responsible for these alterations in blood flow is situated 
upstream of the intercostal orifice. I examined this area in both untreated wild type mice and NF-κB- 
luciferase reporter mice challenged with LPS injections. My findings revealed that RelA levels are 
elevated at the intimal cushion compared to an adjacent area that experiences normal, laminar flow. NF-
κB transcriptional activity was also elevated in this area, indicating that EC exposed to abnormal 
hemodynamics at the intercostal ostia may be primed for enhanced inflammatory activation in response 
to LPS. 
 
These data are in part consistent with other investigators findings as the aortic branching sites are well-
known to be susceptible to atherosclerotic lesion formation. In immature human aortae, it has been 
shown that lesions occur downstream of branch ostia. In contrast, at later ages lesions develop in a 
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more lateral or upstream distribution and are plausible to be caused by prolonged abnormalities in the 
hemodynamic environment. In mice, this pattern is to a greater extent inconsistent (McGillicuddy et al., 
2001). It would be interesting therefore to see whether NF-κB transcriptional activities at the aortic 
branch correspond to the elevated RelA protein level upstream of the ostia. This would demand an 
alternative strategy than can assess NF-κB activities at a single cell resolution e.g. through analysis of 
transgenic mice in which NF-κB drives GFP expression (this strain is currently under development in 
the Department of Nutrition, University of Oslo). 
 
4.3 Expression of selected NF-κB target genes in atherosusceptible and 
atheroresistant regions of the murine aorta 
To investigate the functional consequences of NF-κB activation in LP and HP sites of the murine aorta 
we evaluated the expression levels of VCAM-1 and A1, genes whose induced expression depends on 
NF-κB activation.  
 
4.3.1 EC at atherosusceptible sites are primed for enhanced expression of the pro-
inflammatory NF-κB target gene VCAM-1 in response to LPS 
In the untreated aortic endothelium, I found that the constitutive levels of VCAM-1 are very low. At this 
level of fluorescence signal, the quantitation did dot reveal a highly significant difference between the 
HP and the LP regions. However, other groups have shown that VCAM-1 levels are elevated at 
atheroprone regions of the normal C57BL/6 mouse by using a more sensitive system that utilised 
quantum dot nanocrystals and two-photon excitation laser scanning microscopy (Ferrara et al., 2005). 
 
In contrast, by activating the endothelium with acute systemic stimuli for 6 hours, we could see that 
VCAM-1 expression levels were significantly increased throughout the aorta, but especially at the HP 
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region. A number of other investigators have studied the expression of VCAM-1 in murine aortae, and 
the findings are consistent with this study (Iiyama et al., 1999; Nakashima et al., 1998). 
 
If we compare this finding with the pattern we observed for the RelA/NF-κB expression, we can notice 
the similarities in the spatial distribution. This suggests that VCAM-1 activity is correlated to NF- κB 
transcriptional activity. Consequently, a strong correlation between nuclear translocation of RelA and the 
expression of pro-inflammatory transcripts is established. 
 
4.3.2 Expression of the cytoprotective protein A1 is upregulated by LPS in the murine aorta 
My findings revealed that the unstimulated aortic endothelium expressed very low levels of A1 protein. 
However, upon systemic acute activation by LPS, an increase in A1 protein was observed. The HP 
(exposed to low shear) and LP (high shear) regions did not show a significant difference in the 
expression of A1. These data are consistent with studies of cultured EC that demonstrated that the 
induction of A1 by pro-inflammatory stimuli is not regulated by shear stress (Duriez et al., 2000). 
 
These findings on the expression of A1 were assessed in BXSB 1,4 mice and are not directly 
comparable with my other findings which were carried out in C57BL/6 mice. These data should 
therefore be looked at as preliminary findings which now need to be validated in a wild type strain of 
mice (BL/6). Unfortunately, time did not allow for me to do these final experiments before submitting the 
thesis, but will be finished by one of my co-workers within the Intracellular Signaling group.   
 
4.3.3 NF-κB target genes are induced by LPS treatment 
My studies suggest that the relatively high levels of NF-κB components in the HP region are functionally 
quite responsive, whereas the NF-κB signal transduction pathway in the LP region was largely 
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quiescent. Although we saw initial NF-κB activation of the LP region in response to LPS, this effect may 
therefore have been quickly repudiated. Differences in the expression of VCAM-1 and A1 may also 
reflect different sensitivities of the genes to NF-κB activation. 
 
Theoretically, CD31 could be used as a control for the above experiments, because the expression of 
this protein is constitutive, not upregulated by LPS or cytokines and thought to be independent of NF-κB 
activation. We found that the efficiency of staining of CD31 was inconsistent between experiments. This 
may be due to incomplete antibody binding or other technical reasons. We decided therefore not to use 
CD31 staining as a negative control, but merely as an endothelial marker.  
 
4.4 Does high shear stress mediate atheroprotective effects in aortic 
endothelium by activating Nrf2 
Previously, the Nrf2/EpRE pathway has been identified as a system for antioxidant protection and 
suppression of redox-sensitive inflammatory genes (Chen et al., 2005). This suggests that targeting the 
Nrf2/EpRE pathway may represent a novel therapeutic approach for the treatment of inflammatory 
diseases such as atherosclerosis. Nrf2 activity in cultured EC can be upregulated by laminar flow, but 
the mechanism by which biomechanical forces induce Nrf2 activation is not well understood. It has 
previously been suggested that Nrf2 may be an important negative regulator of inflammation in arteries 
exposed to high shear e.g. the LP region. 
 
In this study it was revealed that Nrf2 expression was more prevalent in the HP area of the aortic arch 
compared to the LP region. I also found that there was no difference in the extent of nuclear 
translocation in the HP or LP regions. Collectively, these data suggest that Nrf2 activation may be 
higher in the HP region than the LP region, which is the opposite of what we expected. Dai et al. have 
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recently suggested that Nrf2 is predominantly nuclear localized in the atherosclerosis-resistant region, 
whereas its localization is diffuse in the susceptible region (Dai et al., 2007). Similar findings have 
previously been shown in cultured endothelial cells (Hosoya et al., 2005). My findings are therefore 
inconsistent with those of Dai et al. and further experiments will be required to address this.  
 
To validate my findings, the specificity of the primary antibody I used in this experiment needs to be 
assessed. By examining antibody binding to the aortic endothelium in Nrf2 gene knockout mice we can 
assess whether the epitope binding is specific to Nrf2 or whether non-specific binding can occur.  
 
I used an alternative technology employing transgenic mice containing an ARE/EpRE-luciferase reporter 
gene to further investigate Nrf2 activity in the murine aorta. Luminescence data showed a patchy 
distribution of Nrf2 activity that did not correlate with anatomical references of different flow patterns. 
Quantitation revealed that there were little or no differences in Nrf2 activity in the HP or LP region of the 
aortic arch. We were surprised by the low constitutive Nrf2 level in these aortae, since the 
immunofluorescence staining showed such high protein amounts. Thus, it would be interesting to 
investigate possible differences of neighbouring cells. To do this, we would need to assess Nrf2 activity 
at a single cell resolution by using anti-luciferase antibodies and fluorescence LSM. 
 
4.5 Spatial distribution of NF-κB activity in the aorta and its relevance in 
atherosclerosis 
The most important finding of my study was that the NF-κB signal transduction pathway in endothelium 
of atherosusceptible regions was primed for enhanced responses to systemic activation stimuli. Thus 
lipopolysaccharide treatment resulted in NF-κB activation and up-regulated expression of NF-κB 
inducible genes predominantly in EC of the HP region.  
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One may speculate whether the NF-κB signal transduction pathway is upregulated or chronically 
activated in HP regions or downregulated in LP regions. Chronic exposure to laminar shear stress may 
upregulate the expression of unique genes such as Nrf2 that are atheroprotective, or may promote other 
mechanisms that actively repress expression of broad category of genes. Several groups have 
demonstrated that alterations in fluid dynamics induced by surgery to modify the geometry of vessels in 
conjunction with hypercholesterolemia can influence atherosclerotic lesion formation (Fishman et al 
1975, Booth et al 1989), which further supports the role of hemodynamics in lesion development. Given 
the findings presented in this thesis, it would be very interesting to investigate whether such alterations 
in fluid dynamics can also alter the expression of NF-κB subunits, NF-κB transcriptional activity and 
pro-inflammatory activation in vivo, factors that are central regulators of the atherogenic process.  
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5 Conclusion 
 
In this study I sought to investigate the correlation between atherosclerosis, hemodynamic flow patterns 
and the NF-κB signal transduction pathway. I found that the expression of RelA NF-κB subunits and 
NF-κB transcriptional activity was elevated in regions of the aortic endothelium exposed to low, 
oscillatory shear (HP region, ostia). I also demonstrated that the NF-κB-dependent pro-inflammatory 
molecule VCAM-1 was significantly increased in the HP region in response to systemic activation 
stimulus. In contrast, the anti-apoptotic, cytoprotective protein A1 was elevated in both HP and LP 
regions on encounter with LPS. The distribution of Nrf2 expression and activity did not vary between 
high shear and low shear regions, thus alternative studies will be required to fully assess the potential 
role of this transcription factor in atheroprotection. 
 
Collectively, my findings suggest that murine aortic endothelial cells exposed to low shear stress are 
primed for enhanced NF-κB activation which drives pro-inflammatory activation, whereas endothelium 
in an environment of laminar unidirectional flow is protected. We can therefore conclude that the NF-κB 
pathway may have a prominent role in the initiation and progression of atherosclerotic lesions, and may 
serve as a target for novel therapies to prevent and treat atherosclerosis. 
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